The plasma levels and diagnostic utility of granulocyte - colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients;Stȩżenie i przydatność diagnostyczna czynnika stymuluja̧cego kolonie granulocytarne (G-CSF) i makrofagalne (M-CSF) w osoczu chorych na raka jajnika

Polski Merkuriusz Lekarski

Volumn 21, Issue 125, 2006, Pages 465-468

  Ławicki, Sławomir ^a   Czygier, Małgorzata ^a   Gacuta Szumarska, Ewa ^a   Knapp, Paweł ^a   Szmitkowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Granulocyte colony stimulating factor (G CSF); Macrophage colony stimulating factor (M CSF); Ovarian cancer; Tumour markers

Indexed keywords

CA 125 ANTIGEN; COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC PROCEDURE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; OVARY CANCER; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; BLOOD; CYSTADENOCARCINOMA; MIDDLE AGED; OVARY TUMOR; PREDICTION AND FORECASTING;

ADULT; AGED; CA-125 ANTIGEN; CYSTADENOCARCINOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MIDDLE AGED; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33845295459     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Asschert J.G.W., Vellenga E., Hollema H. et al.: Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (IL-6), interleukin-1β (IL-1β), interlekin-11 (IL-11) and tumour necrosis factor-α (TNF-α) in p53-characterised human ovarian carcinomas. Eur. J. Cancer, 1997, 33, 2246-2251.
2. Baba M., Hasegawa H., Nakayabu M.: Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels G-CSF, GM-CSF, and IL-6: The presence of autocrine growth control by G-CSF. Amer. J. Hemat., 1995, 49, 207-216.
3. Cooper B.C., Sood A.K., Davis C.S. et al.: Preoperative CA 125 levels: An independent prognostic factor for epithelial ovarian cancer. Obstet. Gynecol., 2000, 100, 59-64.
4. Chao K., Chang C., Yen M. et al.: Granulocyte colony-stimulating factor on the growth of human ovarian carcinoma cells in vitro. Gynecol. Obstet. Invest., 1999, 48, 280-284.
5. Czygier M., Ławicki S., Szmitkowski M. i wsp., Stȩżenie wzrostowego czynnika granulopoezy (G-CSF) w osoczu i aktywność enzymów w granulocytach u chorych na raka piersi. Gin. Pol., 2004, 75, 99-104.
6. Dembińska-Kieć A., Naskalski J.W.: Pojȩcie normy wartości referencyjnych i ich znaczenie dla formułowania diagnozy. (w) Diagnostyka laboratoryjna z elementami biochemii klinicznej. Dembińska-Kieć A., Naskalski J.W. (red.). Urban&Partner, Wrocław, 2002, 4, 47-57.
7. Ebert A.D., Wechselberger C., Martinez-Lacaci I. et al.: Expression of function of EGF-related peptides and their receptors in gynecological cancer - from basic science to therapy. J. Recept. Signal. Transduct. Res., 2000, 20, 1-46.
8. Hintzen R.Q., Voormolen J., Sonneveld P.: Glioblastoma causing granulocytosis by secretion of granulocyte - colony stimulating factor. Neurology, 2000, 54, 259-261.
9. Inoue M., Kyo S., Fujita M.: Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res., 1994, 54, 3049-3056.
10. Jeyarajah A.R., Ind T.E., Skates S. et al.: Serum CA 125 elevation and risk of clinical detection of cancer asymptomatic postmenopausal women. Cancer, 1999, 85, 2068-2072.
11. Juengel J.L., Quirke L.D., Tisdall D.J. et al.: Gene expression in abnormal ovarian structures of ewes homozygous for the inverdale prolificacy gene. Biol. Reproduction, 2000, 62, 1467-1478.
12. Kim H.K., Song K.S., Kim H.O. et al.: Circulating numbers of endothelial progenitors cells in patients with gastric and breast cancer. Cancer Lett., 2003, 198, 83-88.
13. Kozakiewicz B., Nowotwory złośliwe narza̧du rodnego. Nowa Medycyna, 2003, 122, 111-27.
14. Ławicki S., Mroczko B., Szmitkowski M.: Cytokiny hematopoetyczne jako markery choroby nowotworowej. Post. Hig. Med. Dośw., 2001, 55, 449-465.
15. Ławicki S., Omyła j., Mroczko B. i wsp.: Stȩżenie w osoczu czynnika wzrostu kolonii makrofagowych (M-CSF) w przebiegu leczenia raka piersi. Pol. Archiw. Med. Wew., 2004, 4, 1191-1197.
16. McDermott R.S., Deneux L., Mosseri V. et al.: Circulating macrophage colony stimulating factor as a marker of tumour progression. Eur. Cytokine Network., 2002, 13, 121-127.
17. Mroczko B., Szmitkowski M., Nikliński J.: Granulocyte - colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in patients with non-small-cell lung cancer. Clin. Chem. Lab. Med., 2001, 39, 374-379.
18. Munn D.H., Cheung N.K.V.: Preclinical and clinical studies of macrophage - colony stimulating factor. Semin. Oncol., 1992, 19, 395-407.
19. Nagashima R., Mabe K., Takahashi T.: Esophageal small cell carcinoma with ectopic production of parathyroid hormone-related protein (PTHrp), secretin, and granulocyte colony-stimulating factor. Dig. Dis. Sci., 1999, 44, 1312-1316.
20. Padungsutt P., Thirapagawong C., Senapad S. et al.: Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy. Anticancer Res., 2000, 20, 1291-1295.
21. Punnonen R., Teisala K., Kuoppala T. et al.: Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors. Cancer, 1998, 83, 788-796.
22. Rutkowski P., Kamińska J., Kowalska M. et al.: Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis. Int. J. Cancer, 2002, 100, 463-471.
23. Savarese T.M., Mitchell K., McQain C. et al.: Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas. Cancer Letters, 2002, 162, 105-115.
24. Savarese D.M.F., Valinski H., Quesenberry P. et al.: Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate, 1998, 34, 80-91.
25. Scholl S.M., Bascou C.H., Mosseri V.: Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer. Br. J. Cancer, 1994, 69, 342-346.
26. Suzuki M., Ohwada M., Sato I., Nagamoto M.: Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies. Oncology, 1995, 52, 128-133.
27. Takagi A., Takeda S., Matsuoka K. et al.: Macrophage colony-stimulating factor (M-CSF) production in vivo and in vitro in gynecological malignancies. Blood, 1987, 69, 1409-1413.
28. Xu L., Fidler I.J.: Interleukin 8: An autocrine growth factor for human ovarian cancer. Oncology Res., 2000, 12, 97-106.
29. Xu F.J., Ramakrishnan S., Daly L. et al.: Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. Am. J. Obstet. Gynecol., 1991, 165, 1356-1362.
30. Yedema C.A., Kenemans P, Wobbes T. et al.: Use of serum tumour markers in the differential diagnosis between ovarian and colorectal adenocarcinomas. Tumor Biol., 1992, 13, 18-26.